Daesang Corp (001680)
Korea Stock Exchange · Korea · prices in KRW · close of 23 Oct 2026
Key indicators
| Last close | KRW 16,360.00 |
|---|---|
| 52-week range | 15,880.00 – 24,150.00 |
| Return, 1 month / 3 months | −8.1% / −6.4% |
| Return, 1 year / 3 years | −18.4% / −4.8% |
| Trend | Below its 200-day average |
| RSI (14) | 27 |
| Volatility (1 year) | 29.0% |
| Worst drawdown (1 year) | -30.6% |
| Average daily value traded | 1,899.60M KRW |
| Dividend yield | 5.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Daesang Corp is a Korean food and ingredients company based in Seoul. It makes fermented seasonings and condiments, including soy sauce, soybean paste and chili paste, along with processed foods and sweeteners for household and industrial customers. The company also supplies food ingredients such as amino acids, starches and other additives to food manufacturers, and it operates a range of consumer food brands sold through retail channels in Korea and other markets.
Daesang Corp trades under the code 001680 on the Korea Stock Exchange in Korea, with its price quoted in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Daesang Corp (001680) trades on the Korea Stock Exchange in Korea. It last closed at KRW 16,360.00 on 23 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 255 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 18.4% and over the last three months it fell 6.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -14.8% | ||
| From 52-week high | -31.8% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -6.4% | ||
| 6-month return | -22.1% | ||
| 12-month return, skipping the last month | -11.2% | ||
| Stability (higher is calmer) | 83 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 29.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.6% | ||
| Liquidity | 68 · Fair | Moderate trading activity. | |
| Average daily value traded | 1,899.60M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.2% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −8.5% |
|---|---|
| 1 month | −8.1% |
| 3 months | −6.4% |
| 6 months | −22.1% |
| 1 year | −18.4% |
| 3 years | −4.8% |
| 5 years | −18.4% |
Signals
| 50-day / 200-day average | 17,979.60 / 19,211.04 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 466.56 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Mar 2026 | KRW 850.0000 |
| 28 Mar 2025 | KRW 850.0000 |
| 27 Dec 2023 | KRW 800.0000 |
| 28 Dec 2022 | KRW 800.0000 |
| 29 Dec 2021 | KRW 800.0000 |
| 29 Dec 2020 | KRW 700.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.